About US

About Journal

European Journal of Medical and Clinical Oncology (EJMCO) is a multidisciplinary, peer-reviewed online open access journal that aims to publish high quality up-to-date articles within the fields of experimental Medical and clinical oncology.

Journal Features
Frequency of Publication: Quarterly
Language of Publication: English
Format of the Publication: Online


Aim & Scope

EJMCO accepts various formats of literary works such as Research articles, Reviews, Addendums, Announcements, Article-commentaries, Book reviews, Rapid communications, Letters to the editor, Annual meeting abstracts, Conference proceedings, Video articles, Image articles, Calendars, Case-reports, Corrections, Discussions, Meeting-reports, News, Obituaries, Orations, Product reviews, Hypotheses and Analyses.

We are delighted to invite all researchers to submit their original research articles for publication https://urfpublishers.com/journal/european-oncology/online-submission   or send as an e-mail attachment to the Editorial Office at [email protected] The target readership includes academic members or specialists on medicine and oncology following a double-blind peer review mechanism to ensure the standards of its publications.

Topics

Cancer Genetics & Genomics
Cancer Metabolism
Cell Signaling & Regulation
Cell-Based Therapy
Chemical Biology
Computational Oncology
Developmental Biology
Epidemiology, Statistics & Health Outcomes
Epigenetics
Exercise Oncology
Genome Integrity
Hematologic Malignancies
Imaging
Metastasis & Drug Resistance
Microbiome & Inflammation
Molecular Pathology & Diagnostics
Neuroscience & Neuro-Oncology
Solid Tumor Oncogenesis
Nanotechnology to develop more-effective drug-targeting systems and minimally invasive probes for cancer detection and diagnosis.
Stem-cell pluripotency and self-renewal and study stem cells in the context of both normal development and cancer
Understanding how genes and proteins function and gives us essential clues for designing more-effective cancer therapies
Cancer treatments to exploration of the cancer genome, immune system, microbiome, and other areas.
Cancer-promoting processes and pioneering the development of promising new therapies
New possibilities for the development of targeted therapies
Experimental therapeutics in the field of immunotherapy and chemotherapy
Clinical and experimental research in oncology and hematology
Immunobiology, pathogenesis, and treatment of malignant tumors
Treatment & prevention addressing Cancer diagnosis
Cancer Imaging and Image-directed Interventions
Neuro-Oncology and Neurosurgical Oncology
Cancer Molecular Targets and Therapeutics
All aspects of Clinical & Medical Oncology
Noncolorectal Gastrointestinal Cancer
Cancer Immunity and Immunotherapy
Cancer Epidemiology and Prevention
Pharmacology of Anti-Cancer Drugs
Psycho-Oncology Radiotherapy
Basic and Clinical Immunology
Advanced Solid Tumours
HPV and Cervical Cancer
Cancer Pharmacodynamics
Gastrointestinal Cancers
Renal Cell Carcinoma
Cancer Risk Assessment
Clinical Radiation Oncology
Cancer Epidemiology

Journal Features:

International peer review research journal that publishes articles on multidisciplinary fields.

Prompt acknowledgement after receiving the article.

Rigorous double blind peer review evaluation.

No charges for article submission.

Rapid publication after the acceptance of article through eminent reviewers and editor.

Publication of manuscripts with the fulfilment of excellence, novelty and originality.

Nominal publication charges.

Greater visibility of your valuable published work.

Best platform for sharing the knowledge globally.

Issue of Publication Certificate to author.

Issue of Editorial Board Member Certificate to EBM member.

Issue of reviewer Certificate to reviewer.

About UR Forum Publishers

UR Forum Publishers is a scientifically independent open access publisher whose mission is to publish new research by bridging the gap between research and practise, with the goal of resulting in societal benefits. Our peer-reviewed publications cover a wide range of medical research, healthcare, and other topics. We are dedicated to publishing high-quality research articles that have an impact and are long-lasting, resulting in a better future for future generations.

Researchers and academics can use UR Forum Publishers to disseminate scientific knowledge to a wider audience, gain media attention, and demonstrate professional progress through publication. The Open Access concept allows for unrestricted access to published content that is not time-limited, as well as the ability to reprint and distribute original content. We publish the work of eminent scientists, young researchers, and academic and industrial professionals. Because our journals adhere to the criteria and principles of the Directory of Open Access Journals, viewing the full text of articles does not require a subscription (DOAJ).

We are a committed group of educators and technocrats with extensive industry experience. Our torchbearers are eminent scientists, educators, industrialists, and officials from around the world who serve on the editorial board. Our team is working hard to connect available talent and resources in order to form partnerships that will promote research collaboration. Our common goal is to support research and discoveries that benefit the community and advance technology.

By embracing best practises and technology to deliver unique science books, journals, and series, UR Forum has remained at the forefront of academic publishing. Our entry into the exciting world of online publications and eBooks was a natural and seamless transition. This step is an extension of our vision to publish the best works by outstanding scientists from around the world and make them available to as many people as possible.

In almost every country, UR Forum has representatives, agents, and distributors. They provide review copies upon request, advertise academic journals in specialised catalogues, and exhibit at international trade shows such as the London, US, and international academic book events.